Tuesday, July 7, 2015

Pfizer spent big money on lobbying when new PA health department secretary worked there

Pfizer spent big money on lobbying when new PA health department secretary, Michael Wolf, worked there.

Pfizer spent big money on lobbying when new PA health department secretary worked there

0 comments
Official Commonwealth of Pennsylvania Portrait of Michael Wolf
Official Commonwealth of Pennsylvania Portrait of Michael Wolf
Travel Deals

Michael Wolf was named secretary of the Pennsylvania health department by Gov. Corbett on Monday, as Inquirer colleague Amy Worden wrote the other day. A link is here.

Wolf spent more than five years with Pfizer, Inc., the world's largest pharmaceutical company by revenue. Pfizer's headquarters is in Manhattan, but it has a big operation in Collegeville.

From March 2006 through May 2011, Wolf was director of public affairs and policy. Such positions often involve, directly or indirectly, urging government officials to pass rules or laws that help the company.

After that, Wolf went to work in Corbett's administration.

While Wolf was with Pfizer, the company was No. 1 or No. 2 among pharmaceutical companies in annual expenditures on lobbying, according data compiled by opensecrets.org. The web site culls data from campaign finance reports.

According to opensecrets.org, this is the list of Pfizer's annual spending on lobbying and its ranking among pharmaceutical companies during the 2006-2011 period:

  • 2006: $11,800,000 (1)
  • 2007: $13,800,000 (2, behind Amgen)
  • 2008: $12,180,000 (2, behind Eli Lilly)
  • 2009: $25,819,000 (1)
  • 2010: $13,380,000 (1)

2011: $12,890,000 (1)

 

0 comments
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
 
comments powered by Disqus
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

For Inquirer.com. Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at dsell@phillynews.com.

David Sell
Also on Philly.com:
letter icon Newsletter